Active Ingredient History
Enterococcus faecium is a Gram-positive, gamma-hemolytic or non-hemolytic bacterium in the genus Enterococcus. It can be commensal in the gastrointestinal tract of humans and animals, but it may also be pathogenic, causing diseases such as neonatal meningitis or endocarditis. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Air Travel (Phase 2/Phase 3)
Basal Ganglia Diseases (Phase 4)
Brain Diseases (Phase 4)
Central Nervous System Diseases (Phase 4)
Colitis, Ulcerative (Early Phase 1)
Crohn Disease (Phase 1/Phase 2)
Diabetes Mellitus, Type 2 (Phase 4)
Gastrointestinal Microbiome (Phase 4)
Hyperoxaluria (Phase 1/Phase 2)
Irritable Bowel Syndrome (Phase 4)
Movement Disorders (Phase 4)
Nephrolithiasis (Phase 1/Phase 2)
Nervous System Diseases (Phase 4)
Neurodegenerative Diseases (Phase 4)
Parkinson Disease (Phase 4)
Parkinsonian Disorders (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
